Kensington Investment Counsel’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,060
Closed -$805K 100
2023
Q2
$805K Sell
5,060
-1,784
-26% -$288K 0.51% 65
2023
Q1
$1.08M Sell
6,844
-2,203
-24% -$330K 0.82% 47
2022
Q4
$1.27M Sell
9,047
-1,585
-15% -$225K 1% 44
2022
Q3
$1.36M Sell
10,632
-17
-0.2% -$2.45K 1.15% 40
2022
Q2
$1.5M Sell
10,649
-251
-2% -$35.9K 1.28% 32
2022
Q1
$1.51M Buy
10,900
+2,800
+35% +$429K 1% 47
2021
Q4
$1.41M Buy
+8,100
New +$1.35M 0.82% 60

Other funds holding CLX

Kensington Investment Counsel's CLX Position: Q3 2023 in Review

Kensington Investment Counsel sold out of Clorox (CLX) in Q3 2023, closing a stake of 5,060 shares — an estimated $805K sold.

Kensington Investment Counsel first reported a position in CLX in Q4 2021 and held it in 7 quarters. The position peaked at $1.51M in Q1 2022. 1,065 funds tracked by Wall St. Rank hold CLX as of Q3 2023.

  • Kensington Investment Counsel reported no remaining Clorox position as of Q3 2023 after selling out during the quarter.
  • Kensington Investment Counsel sold 5,060 Clorox shares in Q3 2023, an estimated $805K.
  • Kensington Investment Counsel first reported a position in Clorox in Q4 2021 and held it in 7 quarters.
  • Kensington Investment Counsel's Clorox position peaked at $1.51M in Q1 2022.
  • 1,065 funds tracked by Wall St. Rank held Clorox as of Q3 2023.

Based on Kensington Investment Counsel's 13F filing for Q3 2023, filed 9 Nov 2023.